e-Newsletter April 2026
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Search
Search results
Renewed Momentum for XLRP: MeiraGTx Targets Rapid Approval Path for bota-vec following reacquisition from Johnson and Johnson
It has recently been announced that Meira-GTx, who originally developed bota-vec and collaborated with J&J during its early clinical trials, have entered into an asset purchase agreement with J&J to acquire bota-vec and progress the program towards global regulatory filings for approval.
Podcast: Meet the Professionals: Ophthalmologist
The sixth installment of the Retina UK podcast series, Meet the Professionals.